LOMMERS, E., DELRUE, G., REUTER, G., CALAY, P., DELVAUX, V., HANSEN, I., DIVE, D., MAQUET, P., & Phillips, C. (October 2015). Improved probabilistic segmentation of white matter lesions in multiple sclerosis [Poster presentation]. 31st congress of the European Committee for Treatment and Research in Multiple Sclerosis. |
PHAN BA, R., Pierard, S., LOMMERS, E., DELRUE, G., CALAY, P., Van Droogenbroeck, M., DELVAUX, V., & MAQUET, P. (October 2013). Relative Contribution of Walking Speed, Ataxia and Gait asymmetry to the Composition of Gait in Multiple Sclerosis. Multiple Sclerosis Journal, 19 (S1), 261. Peer Reviewed verified by ORBi |
PHAN BA, R., DELRUE, G., Pierard, S., LOMMERS, E., CALAY, P., Van Droogenbroeck, M., & DELVAUX, V. (10 June 2013). Influence of the mode of walk on walking speed in multiple sclerosis: are you walking comfortably? [Poster presentation]. Twenty-third meeting of the European Neurological Society, Barcelona, Spain. |
Delrue, G., Monisse, A., Blavier, A., Nyssen, A.-S., CALAY, P., & Belachew, S. (2013). Entretiens de la Fondation Garches [Paper presentation]. Entretiens de la Fondation Garches, Nanterre, France. |
PHAN BA, R., CALAY, P., GRODENT, P., DELRUE, G., LOMMERS, E., DELVAUX, V., Moonen, G., & Belachew, S. (April 2012). Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis. PLoS ONE, 7 (4), 34744. doi:10.1371/journal.pone.0034744 Peer Reviewed verified by ORBi |
Phan-Ba, R., CALAY, P., GRODENT, P., DELRUE, G., LOMMERS, E., DELVAUX, V., Moonen, G., Nagels, G., & Belachew, S. (2012). A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients. NeuroRehabilitation, 30 (4), 261-266. doi:10.3233/NRE-2012-0754 Peer Reviewed verified by ORBi |
DELRUE, G., MONISSE, A., Blavier, A., Nyssen, A.-S., CALAY, P., & BELACHEW, S. (2012). Construction and pre-validation of a cognitive ergonomics questionnaire for work holding in multiple sclerosis patients : The QUIPSEP [Poster presentation]. 28TH CONGRESS OF THE EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS. |
Phan-Ba, R., LOMMERS, E., TSHIBANDA, L., CALAY, P., DUBOIS, B., Moonen, G., Clifford, D., & Belachew, S. (2012). MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy. Journal of Neurology, Neurosurgery and Psychiatry, 83, 224-226. doi:10.1136/jnnp-2011-300511 Peer Reviewed verified by ORBi |
Phan-Ba, R., Pace, A., CALAY, P., GRODENT, P., DOUCHAMPS, F., Hyde, R., Hotermans, C., DELVAUX, V., HANSEN, I., Moonen, G., & Belachew, S. (March 2011). Comparison of the Timed 25-Foot and the 100-Meter Walk as Performance Measures in Multiple Sclerosis. Neurorehabilitation and Neural Repair, 25 (7), 672-9. doi:10.1177/1545968310397204 Peer Reviewed verified by ORBi |
Belachew, S., Phan-Ba, R., Bartholome, E., Delvaux, V., Hansen, I., Calay, P., El Hafsi, K., Moonen, G., Tshibanda, L., & Vokaer, M. (February 2010). Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis. European Journal of Neurology, 18 (2), 240-245. doi:10.1111/j.1468-1331.2010.03112.x Peer Reviewed verified by ORBi |
Belachew, S., Bartholome E., DELVAUX, V., TSHIBANDA, L., HANSEN, I., CALAY, P., EL HAFSI K., Moonen, G., & VOKAER M. (June 2009). Natalizumab induced freedom from disease activity after failure to previous therapy in relapsing remitting multiple sclerosis [Paper presentation]. 19th Meeting of the European Neurological Society, Milan, Italy. |
Belachew, S., CALAY, P., DELVAUX, V., HYDE, R., Hottermans, C., & Moonen, G. (June 2009). The timed 100-meter walk test: an easy-t-use, sensitive tool to detect and evaluate restricted walking capacities in multiple sclerosis [Paper presentation]. 19th Meeting of the European Neurological Society, Milan, Italy. |